Corporate Profile

Sequenom is committed to improving healthcare through revolutionary genetic analysis solutions.

Sequenom develops innovative technology, products and diagnostic tests that target and serve discovery and clinical research, and molecular diagnostics markets.

The company's proprietary MassARRAY® system is a high-performance DNA analysis platform that efficiently and precisely measures the amount of genetic target material and variations therein. The sy... More >>

Upcoming Webcasts
Bank of America Merrill Lynch 2012 Healthcare Conference
Tuesday, May 15, 2012
1:00pm PDT
Sequenom First Quarter 2012 Earnings Conference Call
Thursday, May 3, 2012
5:00pm EDT
Company Presentations

Bank of America Merrill Lynch 2012 Health Care Conference
May 15, 2012

30th Annual JP Morgan Health Care Conference
January 12, 2012

2011 Analyst and Investor Day
November 14, 2011

Recent News
Email Alerts
May 18, 2012
Study In Prenatal Diagnosis Finds Sequenom CMM's MaterniT21™ PLUS Lab-developed Test Accurately Detects Fetal Trisomies In Pregnant Women Carrying Twins Or Triplets
May 17, 2012
Sequenom Provides Update on Agreement With Coventry Health Care
May 7, 2012
Sequenom Announces Participation at the Bank of America Merrill Lynch Health Care Conference
May 3, 2012
Sequenom, Inc. Reports Financial Results For The First Quarter Of 2012
Apr 19, 2012
Sequenom Announces National Agreement with Provider MultiPlan, Inc.
Price Data

Subscribe to News Alerts